Magnetic vs. wire: which tumor marker is better for breast surgery?
NCT ID NCT06906601
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares two methods for marking non-palpable breast tumors before surgery: magnetic clips and traditional metal wires. Researchers will track costs, how well the marker finds the tumor, and patient satisfaction in 772 women across France. The goal is to see if magnetic clips offer a better or cheaper option for breast-conserving surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- magnetic clip localization
- What this could lead to
- If magnetic clips prove cheaper or better, they could replace wires for marking tumors before breast surgery, improving patient experience and reducing costs.
- What could go wrong
- This is an observational study, not a randomized trial, so results may be biased. It only looks at costs and short-term outcomes, not long-term cancer control.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 772 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2025
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Patients recruited in 7 centers spread across France
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * I1. Female aged ≥ 18 years; * I2. Patient presenting with a unifocal and unilateral lesion of invasive carcinoma or in situ; * I3. Indication for first breast-conserving treatment with the need for preoperative localization of the lesion, regardless of the associated lymph node procedure; * I4. Patient affiliated with a health insurance system; * I5. Non-opposition to the study. Exclusion Criteria: * E.1. Psychological, family, or sociological condition that may potentially compromise adherence to the treatment protocol and follow-up; * E.2. Bilateral surgery required; * E.3. Patient with metastatic breast cancer; * E.4. Multifocal or benign lesions; * E.5. Pregnant or breastfeeding patient; * E.6. Need for neoadjuvant treatment; * E.8. Patient under guardianship, curatorship, or deprived of liberty.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Breast cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
7 sites. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Centre Eugène Marquis
NOT_YET_RECRUITINGRennes, 35042, France
-
Centre Léon Bérard
RECRUITINGLyon, 69008, France
-
Hospices Civils de Lyon Hopital de la Croix rousse
RECRUITINGLyon, 69004, France
-
Hôpital Nord -Ouest Val d'Oise (NOVO)
RECRUITINGPontoise, 95300, France
-
Institut GODINOT
RECRUITINGReims, 51726, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Institut de Cancérologie de Lorraine (ICL)
RECRUITINGNancy, 54519, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a faster radiation course match the standard one after breast reconstruction?
- Can High-Risk breast cancer patients skip an extra radiation boost?
- Radioactive probe lights up CD73 on breast tumors in PET scans
- Can time with horses help cancer patients feel better?
- Can an oral drug replace injections for advanced breast cancer?
- Can a common steroid shield breast cancer patients from a dangerous drug side effect?